✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹67 Cr.
P/E
110.63
  • Biofil Chem & Pharma
  • Ind-Swift
  • JFL Life Sciences
FAQs on Biofil Chemicals & Pharmaceuticals Ltd. Shareprice

Biofil Chem & Pharma has given lower returns compared to its competitors.
Biofil Chem & Pharma has grown at ~-0.63% over the last 2yrs while peers have grown at a median rate of 9.16%

Biofil Chem & Pharma is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Biofil Chem & Pharma is 110, while 3 year average PE is 158.
Also latest EV/EBITDA of Biofil Chem & Pharma is 95.23 while 3yr average is 93.01.

Growth Table
  • Biofil Chemicals & Pharmaceuticals Ltd.
  • Ind-Swift
  • JFL Life Sciences
Balance Sheet
  • Biofil Chemicals & Pharmaceuticals Ltd.
  • Ind-Swift
  • JFL Life Sciences
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Biofil Chemicals & Pharmaceuticals Ltd.
  • Ind-Swift
  • JFL Life Sciences
Cash Flow
  • Biofil Chemicals & Pharmaceuticals Ltd.
  • Ind-Swift
  • JFL Life Sciences
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Biofil Chemicals & Pharmaceuticals Ltd.
  • Ind-Swift
  • JFL Life Sciences
Quarterly Results
  • Biofil Chemicals & Pharmaceuticals Ltd.
  • Ind-Swift
  • JFL Life Sciences
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Biofil Chemicals & Pharmaceuticals Ltd. Financials

Balance sheet of Biofil Chem & Pharma is moderately strong.

Yes, The debt of Biofil Chem & Pharma is increasing.
Latest debt of Biofil Chem & Pharma is ₹0.23 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹4.04 Crs.

The profit is oscillating.
The profit of Biofil Chem & Pharma is ₹0.6 Crs for TTM, ₹0.71 Crs for Mar 2024 and ₹0.56 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Biofil Chem & Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech